Grand Challenges and Opportunities in Deciphering the Role of Non-Coding RNAs in Human Diseases
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Non-coding RNAs (ncRNAs) were at first thought to be a non-specific noise. The vast majority of them have yet to be characterized thoroughly, but many of these ncRNAs are unlikely to represent transcriptional noise as a significant number have been shown to exhibit cell type-specific expression, localization to subcellular compartments, and association with human diseases (Wilusz et al., 2009). Although ncRNAs do not encode protein, this does not mean that such RNAs do not contain information nor have function. Widespread transcription of ncRNAs is now known to occur in all species and they are likely to represent a fundamental
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654 · cited 1×
“In mammals and other eukaryotes, most of the genome is transcribed in a developmentally regulated manner to produce large numbers of lncRNAs (Mercer et al., 2009).”
Cited by
Genomic prediction in CIMMYT maize and wheat breeding programs
Crossa, J., Pérez, P., Hickey, J., Burgueño, J., Ornella, L., Cerón-Rojas, J., Zhang, X., Dreisigacker, S., Babu, R., Li, Y., et al. (2014) · Heredity · doi:10.1038/hdy.2013.16 · Cited by 451
A critical review of sex differences in decision-making tasks: Focus on the Iowa Gambling Task
van den Bos, R., Homberg, J., & de Visser, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.002 · Cited by 325
The risk of maternal obesity to the long‐term health of the offspring
O'Reilly, J. R., & Reynolds, R. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12055 · Cited by 273
Zhu, H., & Leung, S. W. (2015) · Diabetologia · doi:10.1007/s00125-015-3510-2 · Cited by 271
Marine Omega-3 Phospholipids: Metabolism and Biological Activities
Burri, L., Hoem, N., Banni, S., & Berge, K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131115401 · Cited by 257
A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity
Costa, L. G., de Laat, R., Tagliaferri, S., & Pellacani, C. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2013.11.011 · Cited by 256
The origins and genetic interactions of KRAS mutations are allele- and tissue-specific
Cook, J. H., Melloni, G. E. M., Gulhan, D. C., Park, P. J., & Haigis, K. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22125-z · Cited by 208
Panchaud, A., Affolter, M., & Kussmann, M. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2011.12.022 · Cited by 159
Mechanisms of Lipotoxicity in the Cardiovascular System
Wende, A. R., Symons, J. D., & Abel, E. D. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0307-2 · Cited by 110
MicroRNAs as therapeutic targets and their potential applications in cancer therapy
Cho, W. C. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.696102 · Cited by 70
“However, although miRNA-based therapeutics have demonstrated exciting effects in some experiments, the developing progress of antisense or siRNA agents has been hampered by stability, specificity and delivery problems [78].”
BackgroundSelf-citationCirculating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis
Cho, W. C. S. (2011) · Frontiers in Genetics · doi:10.3389/fgene.2011.00007 · Cited by 61
“The identification of a patient who is prognostically good or poor is very important for the development of effective treatment approach (Cho, 2011a).”
Self-citation
Metadata
- Authors
- Cho, W. C. S.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2011
- Volume
- 2
- Pages
- 1-1
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W1968258442
- Cited by
- 126
- References
- 1
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.